Literature DB >> 11160723

Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum.

R E Dickover1, E M Garratty, S Plaeger, Y J Bryson.   

Abstract

Previous studies have provided conflicting data on the presence of selective pressures in the transmission of a homogeneous maternal viral subpopulation to the infant. Therefore, the purpose of this study was to definitively characterize the human immunodeficiency virus type 1 (HIV-1) quasispecies transmitted in utero and intrapartum. HIV-1 envelope gene diversity from peripheral blood mononuclear cells and plasma was measured during gestation and at delivery in mothers who did and did not transmit HIV perinatally by using a DNA heteroduplex mobility assay. Children were defined as infected in utero or intrapartum based on the timing of the first detection of HIV. Untreated transmitting mothers (n = 19) had significantly lower HIV-1 quasispecies diversity at delivery than untreated nontransmittting mothers (n = 18) (median Shannon entropy, 0.711 [0.642 to 0.816] versus 0.853 [0.762 to 0.925], P = 0.005). Eight mothers transmitted a single major env variant to their infants in utero, and one mother transmitted a single major env variant intrapartum. Four mothers transmitted multiple HIV-1 env variants to their infants in utero, and two mothers transmitted multiple env variants intrapartum. The remaining six intrapartum- and two in utero-infected infants had a homogeneous HIV-1 env quasispecies which did not comigrate with their mothers' bands at their first positive time point. In conclusion, in utero transmitters were more likely to transmit single or multiple major maternal viral variants. In contrast, intrapartum transmitters were more likely to transmit minor HIV-1 variants. These data indicate that different selective pressures, depending on the timing of transmission, may be involved in determining the pattern of maternal HIV-1 variant transmission.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160723      PMCID: PMC114803          DOI: 10.1128/JVI.75.5.2194-2203.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study.

Authors:  S H Landesman; L A Kalish; D N Burns; H Minkoff; H E Fox; C Zorrilla; P Garcia; M G Fowler; L Mofenson; R Tuomala
Journal:  N Engl J Med       Date:  1996-06-20       Impact factor: 91.245

2.  State of our knowledge: the epidemiology of HIV/AIDS.

Authors:  A Fontanet; P Piot
Journal:  Health Transit Rev       Date:  1994

3.  Characterization of human immunodeficiency virus type 1 p17 matrix protein motifs associated with mother-to-child transmission.

Authors:  R Narwa; P Roques; C Courpotin; F Parnet-Mathieu; F Boussin; A Roane; D Marce; G Lasfargues; D Dormont
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

4.  Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants.

Authors:  R E Dickover; M Dillon; S G Gillette; A Deveikis; M Keller; S Plaeger-Marshall; I Chen; A Diagne; E R Stiehm; Y Bryson
Journal:  J Infect Dis       Date:  1994-11       Impact factor: 5.226

Review 5.  HIV infection in women: an escalating health concern.

Authors:  S D Saglio; J T Kurtzman; A B Radner
Journal:  Am Fam Physician       Date:  1996-10       Impact factor: 3.292

6.  Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission.

Authors:  N Ahmad; B M Baroudy; R C Baker; C Chappey
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

7.  Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.

Authors:  R E Dickover; E M Garratty; S A Herman; M S Sim; S Plaeger; P J Boyer; M Keller; A Deveikis; E R Stiehm; Y J Bryson
Journal:  JAMA       Date:  1996-02-28       Impact factor: 56.272

8.  Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype.

Authors:  R N Husson; Y Lan; E Kojima; D Venzon; H Mitsuya; K McIntosh
Journal:  J Pediatr       Date:  1995-06       Impact factor: 4.406

9.  Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection.

Authors:  S M Wolinsky; B T Korber; A U Neumann; M Daniels; K J Kunstman; A J Whetsell; M R Furtado; Y Cao; D D Ho; J T Safrit
Journal:  Science       Date:  1996-04-26       Impact factor: 47.728

10.  Analysis of envelope sequence variants suggests multiple mechanisms of mother-to-child transmission of human immunodeficiency virus type 1.

Authors:  L Briant; C M Wade; J Puel; A J Brown; M Guyader
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  40 in total

1.  Viral sequence analysis from HIV-infected mothers and infants: molecular evolution, diversity, and risk factors for mother-to-child transmission.

Authors:  Philip L Bulterys; Sudeb C Dalai; David A Katzenstein
Journal:  Clin Perinatol       Date:  2010-12       Impact factor: 3.430

2.  HIV-1 Transmission, Replication Fitness and Disease Progression.

Authors:  Tasha Biesinger; Jason T Kimata
Journal:  Virology (Auckl)       Date:  2008-07-14

3.  Differential selection of specific human immunodeficiency virus type 1/JC499 variants after mucosal and parenteral inoculation of chimpanzees.

Authors:  Qing Wei; Patricia N Fultz
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 4.  Immunotherapies to prevent mother-to-child transmission of HIV.

Authors:  Mark D Hicar
Journal:  Curr HIV Res       Date:  2013-03       Impact factor: 1.581

5.  Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates.

Authors:  Shixia Wang; Michael Kishko; Shengqin Wan; Yan Wang; Frank Brewster; Glenda E Gray; Avye Violari; John L Sullivan; Mohan Somasundaran; Katherine Luzuriaga; Shan Lu
Journal:  Hum Vaccin Immunother       Date:  2012-11-01       Impact factor: 3.452

6.  Population genetic analysis of the protease locus of human immunodeficiency virus type 1 quasispecies undergoing drug selection, using a denaturing gradient-heteroduplex tracking assay.

Authors:  L Doukhan; E Delwart
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Maternal Humoral Immune Correlates of Peripartum Transmission of Clade C HIV-1 in the Setting of Peripartum Antiretrovirals.

Authors:  Charmaine P Mutucumarana; Joshua Eudailey; Erin P McGuire; Nathan Vandergrift; Gerald Tegha; Charles Chasela; Sascha Ellington; Charles van der Horst; Athena P Kourtis; Sallie R Permar; Genevieve G Fouda
Journal:  Clin Vaccine Immunol       Date:  2017-08-04

8.  Restricted genetic diversity of HIV-1 subtype C envelope glycoprotein from perinatally infected Zambian infants.

Authors:  Hong Zhang; Damien C Tully; Federico G Hoffmann; Jun He; Chipepo Kankasa; Charles Wood
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

9.  Short communication: HIV type 1 subtype C variants transmitted through the bottleneck of breastfeeding are sensitive to new generation broadly neutralizing antibodies directed against quaternary and CD4-binding site epitopes.

Authors:  Elizabeth S Russell; Suany Ojeda; Genevieve G Fouda; Steven R Meshnick; David Montefiori; Sallie R Permar; Ronald Swanstrom
Journal:  AIDS Res Hum Retroviruses       Date:  2013-01-18       Impact factor: 2.205

10.  The human immunodeficiency virus type 1 envelope confers higher rates of replicative fitness to perinatally transmitted viruses than to nontransmitted viruses.

Authors:  Xiaohong Kong; John T West; Hong Zhang; Danielle M Shea; Tendai J M'soka; Charles Wood
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.